Treatment guideline of radiotherapy for Chinese esophageal carcinoma (draft)

Chinese Journal of Cancer

Volumn 29, Issue 10, 2010, Pages 855-859

  Gao, Xian Shu ^a  

^a Shanghai Branch   (China)

Author keywords

Esophageal neoplasm; Guideline; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHINESE; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG DOSE ESCALATION; ESOPHAGUS CARCINOMA; FOLLOW UP; HUMAN; MULTIPLE CYCLE TREATMENT; PRACTICE GUIDELINE; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; STANDARDIZATION; TUMOR VOLUME;

EID: 79955790897     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10250     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
2. Parkin DM, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980 [J]. Int J Cancer, 1988, 41(2): 184-197.
3. Yin WB, Yu ZH, Xu GZ, et al. Radiation Oncology (The Fourth Edition) [M]. Beijing: Peking Union Medical College Press, 2008: 546-577. [in Chinese]
4. Dong ZW, Gu XS. Clinical Oncology [M]. Beijing: Peoples Medical Publishing House, 2002: 731-802. [in Chinese]
5. Wang XL, Zhang ZF, Tang WY, et al. Long-term follow-up results in patients treated with concurrent radiation and chemotherapy for esophageal carcinoma [J]. Chin J Radiat Oncol, 1995, 4(1): 12-14. [in Chinese]
6. 60Co radiotherapy combined with low dose cisplatin for advanced esophageal carcinoma: a report of 96 cases [J]. Chin J Radiat Oncol, 1997, 7(1): 8. [in Chinese]
7. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group [J]. JAMA, 1999, 281(17): 1623-1627.
8. Zhao KL, Shi XH, Jiang GL, et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study [J]. Int J Radiat Oncol Biol Phys, 2005, 62(4): 1014-1020.
9. Chen LQ. Defining AJCC/UICC Esophageal Cancer TNM Staging 7th Edition (2009) [J]. Chin J Clin Thorac Cardiovasc Surg, 2008, 15(1): 52-55. [in Chinese]
10. The Clinical Non-Operative Staging Group of Esophageal Cancer of China. The criteria of clinical non-operative staging of esophageal cancer (draft) [J]. Chin J Radat Oncol, 2010, 19(3): 179-180. [in Chinese]
11. NCCN Guidelines. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
12. Kuwano H, Nishimura Y, Ohtsu A, et al. Guidelines for diagnosis and treatment of carcinoma of the Esophagus [J]. Esophagus, 2008, 5(3): 117-132.
13. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma [J]. N Engl J Med, 1996, 335(7): 462-467.
14. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma [J]. J Clin Oncol, 2001, 19(2): 305-313.
15. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis [J]. Lancet Oncol, 2007, 8(3): 226-234.
16. Fu JH, Rong TH, Li XD, et al. Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial [J]. Chin J Cancer, 2004, 23(11s): 1473-1476. [in Chinese]
17. Yang H, Fu JH, Hu Y, et al. Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma [J]. Nat J Chin, 2008, 88(45): 3182-3185. [in Chinese]
18. An FS, Huang JQ, Xie YT, et al. A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma [J]. Chin J Oncol, 2003, 25(4): 376-379. [in Chinese]
19. Jin MG, Jiang SC, Chen ZW, et al. Clinical trial of preoperative concurrent chemoradiation followed by surgery versus surgery alone for advanced esophageal carcinoma [J]. Chin J Prev Treat, 2008, 15(23): 1815-1817. [in Chinese]
20. Ténière P, Hay JM, Fingerhut A, et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research [J]. Surg Gynecol Obstet, 1991, 173(2): 123-130.
21. Zieren HU, Müller JM, Jacobi CA, et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study [J]. World J Surg, 1995, 19(3): 444-449.
22. Xiao ZF, Yang ZY, Liang J, et al. Ann Thorac Surg. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients [J]. Ann Thorac Surg, 2003, 75(2): 331-336.
23. Xiao ZF, Yang ZY, Miao YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases [J]. Int J Radiat Oncol Biol Phys, 2005, 62(1): 82-90.
24. Gao XS, Qiao X, Wu F, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma [J]. Int J Radiat Oncol Biol Phys, 2007, 67(2): 389-396.
25. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus [J]. N Engl J Med, 1992, 326(24): 1593-1598.
26. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Arm 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy [J]. J Clin Oncol, 2002, 20(5): 1167-1174.
27. Zhao KL, Ma JB, Liu G, et al. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? [J]. Int J Radiat Oncol Biol Phys, 2010, 76(2): 446-451.
28. Zhu GY, Xia TY, Wang LH, et al. Consensus and controversies on delineation of radiotherapy target volume for patients with non-small cell lung cancer [J]. Chin J Radiat Oncol, 2008, 17(6): 432-436. [in Chinese]
29. Button MR, Morgan CA, Croydon ES, et al. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy [J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 818-823.
30. Qiao XY, Wang W, Zhou ZG, et al. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma [J]. Int J Radiat Oncol Biol Phys, 2008, 70(2): 396-402.
31. Lorchel F, Dumas JL, Noël A, et al. Esophageal cancer: determination of internal target volume for conformal radiotherapy [J]. Radiother Oncol, 2006, 80(3): 327-332.
32. Yaremko BP, Guerrero TM, McAleer MF, et al. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography [J]. Int J Radiat Oncol Biol Phys, 2008, 70(1): 145-153.
33. Lin Q, Gao XS, Qiao XY, et al. Dose escalation of cisplatin with 5-fluorouracil in concurrent chemoradiotherapy for esophageal carcinoma [J]. Chin J Radiat Oncol, 2006, 15(4): 301-304. [in Chinese]
34. The First Oncology Accurate Radiotherapy Meeting of China [C]. Beijing, China, 2006. [in Chinese]